Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis-Reference-Cited by-同舟云学术

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis

Published:2019-03-28 Issue:12 Volume:25 Page:1465-1477
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Petito Valentina,Graziani Cristina,Lopetuso Loris R,Fossati Marco,Battaglia Alessandra,Arena Vincenzo,Scannone Domenico,Quaranta Gianluca,Quagliariello Andrea,Chierico Federica Del,Putignani Lorenza,Masucci Luca,Sanguinetti Maurizio,Sgambato Alessandro,Gasbarrini Antonio,Scaldaferri Franco

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference43 articles.

1. Intestinal Epithelial Cell Autophagy Is Required to Protect against TNF-Induced Apoptosis during Chronic Colitis in Mice

2. Inflammatory bowel disease: Progress and current concepts of etiopathogenesis

3. Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends

4. Mir-Madjlessi SH, Michener WM, Farmer RG. Course and prognosis of idiopathic ulcerative proctosigmoiditis in young patients. J Pediatr Gastroenterol Nutr 1986; 5: 571-575

5. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Milk‐derived extracellular vesicles functionalized with anti‐tumour necrosis factor‐α nanobody and anti‐microbial peptide alleviate ulcerative colitis in mice;Journal of Extracellular Vesicles;2024-06

2. Combined administration of anisodamine and neostigmine alleviated colitis by inducing autophagy and inhibiting inflammation;PLOS ONE;2024-02-14

3. Pathological mechanism and targeted drugs of ulcerative colitis: A review;Medicine;2023-09-15

4. Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease;Frontiers in Microbiology;2023-02-23

5. The Crosstalk between Microbiome and Immunotherapeutics: Myth or Reality;Cancers;2022-09-24